Data / Drug companies / Potassium chloride
Potassium chloride: 84 companies and 266 products in the FDA NDC directory
Potassium chloride is listed in the FDA National Drug Code Directory by 84 companies, with 266 products in commercial distribution. 229 of the products (86.1%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; tablet, film coated, extended release; solution, and the newest product started marketing on August 24, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 84
- Products
- 266
- Generic (ANDA) products
- 229 (86.1%)
- Application numbers
- 63
- Routes
- Oral, Intravenous, Sublingual, Parenteral, Topical
- Brand names
- Kali Muriaticum, Klor-Con, Klor-Con M, Pokonza, Sore Throat 911, Kalium Muriaticum 6X, Kali Muriaticum Kit Refill, Kali Muriaticum
- openFDA record search
- api.fda.gov
Companies that list potassium chloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 20 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | November 14, 2023 |
| Boiron | 10 | pellet | Unapproved homeopathic products | March 3, 1983 |
| Bryant Ranch Prepack | 10 | tablet, extended release | Generic drugs (ANDA) | April 10, 2023 |
| Advagen Pharma Ltd | 9 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | August 22, 2024 |
| Aphena Pharma Solutions - Tennessee, LLC | 9 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | August 8, 2025 |
| Upsher-Smith Laboratories, LLC | 8 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | August 15, 2025 |
| Granules Pharmaceuticals Inc. | 7 | capsule, extended release; tablet, extended release | Generic drugs (ANDA) | September 1, 2023 |
| Major Pharmaceuticals | 7 | tablet, extended release; solution | Generic drugs (ANDA) | February 4, 2026 |
| American Health Packaging | 6 | tablet, extended release; capsule, extended release | Generic drugs (ANDA) | March 28, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 6 | capsule, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | November 14, 2023 |
| Aurobindo Pharma Limited | 5 | tablet, extended release; solution | Generic drugs (ANDA) | November 20, 2025 |
| Bryant Ranch Prepack | 5 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | June 17, 2020 |
| Camber Pharmaceuticals, Inc. | 5 | tablet, extended release; solution | Generic drugs (ANDA) | December 26, 2024 |
| Fresenius Kabi USA, LLC | 5 | injection | Generic drugs (ANDA) | June 25, 2021 |
| Lupin Pharmaceuticals,Inc. | 5 | tablet, extended release; solution | Generic drugs (ANDA) | November 21, 2018 |
| AvKARE | 4 | tablet, extended release; capsule, extended release | Generic drugs (ANDA) | August 8, 2025 |
| Macleods Pharmaceuticals Limited | 4 | solution; tablet, film coated, extended release | Generic drugs (ANDA) | September 8, 2024 |
| Northwind Health Company, LLC | 4 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | October 25, 2022 |
| Pai Holdings, LLC DBA Pai Pharma | 4 | solution | Generic drugs (ANDA) | March 27, 2023 |
| Remedyrepack Inc. | 4 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | November 21, 2025 |
| Slate Run Pharmaceuticals, LLC | 4 | tablet, film coated, extended release | Generic drugs (ANDA) | February 1, 2020 |
| Sun Pharmaceutical Industries, Inc. | 4 | capsule, extended release; tablet, extended release | Generic drugs (ANDA) | November 14, 2023 |
| Upsher-Smith Laboratories, LLC | 4 | tablet, film coated, extended release; tablet, extended release | New drug applications (NDA) | November 20, 1998 |
| Upsher-Smith Laboratories, LLC | 4 | tablet, extended release | Generic drugs (ANDA) | October 28, 2024 |
| Zydus Pharmaceuticals USA Inc. | 4 | tablet, extended release; capsule, extended release | Generic drugs (ANDA) | February 3, 2022 |
| AvPAK | 3 | solution; capsule, extended release | Generic drugs (ANDA) | January 26, 2023 |
| Baxter Healthcare Corporation | 3 | injection, solution | New drug applications (NDA) | December 26, 1989 |
| BluePoint Laboratories | 3 | capsule, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | July 10, 2024 |
| Bryant Ranch Prepack | 3 | tablet, extended release; capsule, extended release | Generic drugs (ANDA) | January 1, 2021 |
| Carwin Pharmaceutical Associates, LLC | 3 | powder, for solution; liquid | New drug applications (NDA) | January 14, 2026 |
| Epic Pharma, LLC | 3 | tablet, film coated, extended release; powder, for solution | Generic drugs (ANDA) | August 7, 2023 |
| Guardian Drug Company | 3 | solution; powder, for solution | Generic drugs (ANDA) | July 22, 2025 |
| Hospira, Inc. | 3 | injection, solution, concentrate | Generic drugs (ANDA) | November 10, 2005 |
| Icu Medical Inc. | 3 | injection, solution | New drug applications (NDA) | April 1, 2019 |
| Kesin Pharma Corporation | 3 | solution; powder, for solution | Generic drugs (ANDA) | October 24, 2022 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 3 | tablet, film coated, extended release; capsule, extended release | Generic drugs (ANDA) | August 7, 2023 |
| Nexus Pharmaceuticals LLC | 3 | injection | Generic drugs (ANDA) | February 28, 2021 |
| Proficient Rx LP | 3 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | August 7, 2023 |
| Strides Pharma Science Limited | 3 | tablet, extended release; powder, for solution | Generic drugs (ANDA) | October 24, 2022 |
| XLCare Pharmaceuticals, Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | March 4, 2021 |
| Adare Pharmaceuticals Inc | 2 | capsule | Generic drugs (ANDA) | April 1, 2018 |
| Ajenat Pharmaceuticals LLC | 2 | solution | Generic drugs (ANDA) | March 23, 2026 |
| Amneal Pharmaceuticals NY LLC | 2 | solution | Generic drugs (ANDA) | July 24, 2018 |
| Aurobindo Pharma Limited | 2 | tablet, film coated, extended release | Generic drugs (ANDA) | December 19, 2018 |
| Bpi Labs LLC | 2 | solution | Generic drugs (ANDA) | July 4, 2023 |
| Cardinal Health 107, LLC | 2 | powder, for solution; tablet, extended release | Generic drugs (ANDA) | August 24, 2026 |
| Cranbury Pharmaceuticals, LLC | 2 | solution | Generic drugs (ANDA) | January 26, 2022 |
| Dr. Reddy's Laboratories Inc. | 2 | solution | Generic drugs (ANDA) | July 25, 2022 |
| Fresenius Kabi USA, LLC | 2 | injection, solution, concentrate | Generic drugs (ANDA) | September 5, 2000 |
| Genus Lifesciences | 2 | powder, for solution; solution | New drug applications (NDA) | September 7, 2015 |
| Granules India Limited | 2 | capsule, extended release | Generic drugs (ANDA) | January 1, 2023 |
| HF Acquisition Co LLC, DBA HealthFirst | 2 | injection, solution, concentrate | Generic drugs (ANDA) | October 18, 2019 |
| Henry Schein, Inc. | 2 | injection, solution, concentrate | Generic drugs (ANDA) | January 13, 2022 |
| Mylan Pharmaceuticals Inc. | 2 | tablet, film coated, extended release | Generic drugs (ANDA) | November 9, 2016 |
| Northwind Health Company, LLC | 2 | tablet, extended release | Generic drugs (ANDA) | June 12, 2026 |
| Quagen Pharmaceuticals LLC | 2 | solution | Generic drugs (ANDA) | December 16, 2021 |
| Redpharm Drug | 2 | tablet, extended release | Generic drugs (ANDA) | July 26, 2016 |
| Rising Pharma Holdings, Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | February 13, 2025 |
| Solco Healthcare US, LLC | 2 | capsule, extended release | Generic drugs (ANDA) | April 30, 2019 |
| Zydus Lifesciences Limited | 2 | tablet, extended release | Generic drugs (ANDA) | February 3, 2022 |
| Actavis Pharma, Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | April 10, 2002 |
| Amneal Pharmaceuticals NY LLC | 1 | for solution | Generic drugs (ANDA) | November 25, 2023 |
| Amneal Pharmaceuticals of New York LLC | 1 | capsule, extended release | Generic drugs (ANDA) | February 22, 2013 |
| Ani Pharmaceuticals, Inc. | 1 | for solution | Generic drugs (ANDA) | July 19, 2023 |
| Atlantic Biologicals Corp. | 1 | solution | Generic drugs (ANDA) | July 24, 2018 |
| B. Braun Medical Inc. | 1 | injection, solution, concentrate | Generic drugs (ANDA) | May 2, 2022 |
| Coupler LLC | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | August 21, 2026 |
| DelCorean, LLC | 1 | lotion | Unapproved homeopathic products | March 9, 2020 |
| Direct_Rx | 1 | tablet, extended release | Generic drugs (ANDA) | October 2, 2019 |
| Dna Labs, Inc. | 1 | solution | Unapproved homeopathic products | January 1, 1990 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 1 | powder, for solution | Generic drugs (ANDA) | March 26, 2023 |
| Hyland's Inc. | 1 | tablet | Unapproved homeopathic products | January 1, 1940 |
| Ipg Pharmaceuticals, Inc. | 1 | for solution | New drug applications (NDA) | December 1, 2025 |
| Lupin Pharmaceuticals, Inc. | 1 | capsule, coated, extended release | Generic drugs (ANDA) | January 18, 2016 |
| NorthStar Rx LLC | 1 | capsule, extended release | Generic drugs (ANDA) | January 20, 2016 |
| NorthStar RxLLC | 1 | powder, for solution | Generic drugs (ANDA) | October 6, 2025 |
| Novel Laboratories, Inc. | 1 | for solution | Generic drugs (ANDA) | November 21, 2018 |
| Par Health USA, LLC | 1 | powder, for solution | New drug applications (NDA) | September 18, 2015 |
| Preferred Pharmaceuticals Inc. | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | September 19, 2022 |
| Saptalis Pharmaceuticals, LLC. | 1 | solution | Generic drugs (ANDA) | October 5, 2023 |
| Seroyal USA | 1 | tablet | Unapproved homeopathic products | October 23, 2015 |
| Somerset Therapeutics, LLC | 1 | for solution | Generic drugs (ANDA) | April 10, 2025 |
| St. Mary's Medical Park Pharmacy | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | June 19, 2026 |
| Washington Homeopathic Products | 1 | pellet | Unapproved homeopathic products | November 7, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, extended release | 86 | 32.3% |
| Tablet, film coated, extended release | 49 | 18.4% |
| Solution | 41 | 15.4% |
| Capsule, extended release | 25 | 9.4% |
| Powder, for solution | 15 | 5.6% |
| Pellet | 11 | 4.1% |
| Injection, solution, concentrate | 10 | 3.8% |
| Injection | 8 | 3% |
| For solution | 7 | 2.6% |
| Injection, solution | 6 | 2.3% |
| Capsule, coated, extended release | 2 | 0.8% |
| Capsule | 2 | 0.8% |
| Tablet | 2 | 0.8% |
| Liquid | 1 | 0.4% |
| Lotion | 1 | 0.4% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 229 | 86.1% |
| New drug applications (NDA) | 22 | 8.3% |
| Unapproved homeopathic products | 15 | 5.6% |
Pharmacologic classes
| Class | Products |
|---|---|
| Osmotic Laxative | 256 |
| Potassium Salt | 256 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.